Harnessing exosomes as cancer biomarkers in clinical oncology
Cancer Cell International · 07.08.2024 · 24 (1)
DOI: 10.1186/s12935-024-03464-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Cell International, online erschienen am 07.08.2024. Verfasst von Subhrojyoti Ghosh und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Indian Institute of Technology, Madras, Chennai, 600036, India. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT).
Abstract (Originalsprache)
Exosomes are extracellular vesicles well known for facilitating cell-to-cell communication by distributing essential macromolecules like proteins, DNA, mRNA, lipids, and miRNA. These vesicles are abundant in fluids distributed throughout the body, including urine, blood, saliva, and even bile. They are important diagnostic tools for breast, lung, gastrointestinal cancers, etc. However, their application as cancer biomarkers has not yet been implemented in most parts of the world. In this review, we discuss how OMICs profiling of exosomes can be practiced by substituting traditional imaging or biopsy methods for cancer detection. Previous methods like extensive imaging and biopsy used for screening were expensive, mostly invasive, and could not easily provide early detection for various types of cancer. Exosomal biomarkers can be utilized for routine screening by simply collecting body fluids from the individual. We anticipate that the use of exosomes will be brought to light by the success of clinical trials investigating their potential to enhance cancer detection and treatment in the upcoming years.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, Indian Institute of Technology, Madras, Chennai, 600036, India.
- Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu, 41944, Republic of Korea.
- Advance Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai, 410210, India.
- Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology, Delhi, Delhi, 110016, India.
- Department of Biotechnology, Heritage Institute of Technology, Kolkata, 700107, India.
- Department of Chemistry and Chemical Biology, Indian Institute of Technology (Indian School of Mines), Dhanbad, Jharkhand, 826004, India.
Förderung
- National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT)
Zitieren
APA
Ghosh, S., Rajendran, R. L., Mahajan, A. A., Chowdhury, A., Bera, A., Guha, S., Chakraborty, K., Chowdhury, R., Paul, A., Jha, S., Dey, A., Dubey, A., Gorai, S., Das, P., Hong, C. M., Krishnan, A., Gangadaran, P., & Ahn, B. C. (2024). Harnessing exosomes as cancer biomarkers in clinical oncology. Cancer Cell International, 24(1). https://doi.org/10.1186/s12935-024-03464-5
Vancouver
Ghosh S, Rajendran RL, Mahajan AA, Chowdhury A, Bera A, Guha S, et al. Harnessing exosomes as cancer biomarkers in clinical oncology. Cancer Cell International. 2024;24(1). doi:10.1186/s12935-024-03464-5
BibTeX
@article{Ghosh2024,
author = {Ghosh, Subhrojyoti and Rajendran, Ramya Lakshmi and Mahajan, Atharva A and Chowdhury, Ankita and Bera, Aishi and Guha, Sudeepta and Chakraborty, Kashmira and Chowdhury, Rajanyaa and Paul, Aritra and Jha, Shreya and Dey, Anuvab and Dubey, Amit and Gorai, Sukhamoy and Das, Purbasha and Hong, Chae Moon and Krishnan, Anand and Gangadaran, Prakash and Ahn, Byeong-Cheol},
title = {Harnessing exosomes as cancer biomarkers in clinical oncology},
journal = {Cancer Cell International},
year = {2024},
volume = {24},
number = {1},
doi = {10.1186/s12935-024-03464-5}
}
EUVIMED